论文部分内容阅读
抗血小板药氯吡格雷在英国、德国上市Bristol－MyersSquibb公司的口服抗血小板药氯毗格雷（clopidogrel，商品名Plavix）已在英国和德国上市。本品适用于有缺血性中风、心肌梗死和外周血管疾病史的病人以降低其中风、心肌梗死和血管坏死的发生率。本品是在欧洲上市的第一个二磷
Antiplatelet Agent Clopidogrel Launched in UK and Germany Bristol-Myers Squibb’s oral antiplatelet clopidogrel (Plavix) is available in the UK and Germany. This product is suitable for patients with ischemic stroke, myocardial infarction and peripheral vascular disease history to reduce the incidence of stroke, myocardial infarction and vascular necrosis. This product is the first diphosphate listed in Europe